Grace Therapeutics, Inc. Capital Expenditures Incurred but Not yet Paid
Grace Therapeutics, Inc. (GRCE) reported Capital Expenditures Incurred but Not yet Paid of $9.00 thousand for the 3-month period ending 2019-12-31, per its 10-Q filed 2021-02-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2021-02-09
- Grace Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2019-12-31 was $9.00K.
- Grace Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2019-09-30 was $219.00K.
- Grace Therapeutics, Inc. capital expenditures incurred but not yet paid for the quarter ending 2019-06-30 was $17.00K.
- Grace Therapeutics, Inc. capital expenditures incurred but not yet paid for fiscal 2019 was $9.00.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2019-12-31 | $9.00K 10-Q · filed 2021-02-09 | $228.00K derived: sum of 2 quarters · filed 2021-02-09 | $9.00K 10-Q · filed 2021-02-09 | |
| 2019-09-30 | $219.00K 10-Q · filed 2020-11-16 | $236.00K derived: sum of 2 quarters · filed 2020-11-16 | $219.00K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $17.00K 10-Q · filed 2020-08-13 | |||
| 2019-03-31 | $9.00 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |